Metropolis Healthcare has announced a joint venture with Bramser Corporation. The joint venture company, Metropolis Brasmer Lab Services will now offer pathology services to the island country.

To begin with, Metropolis has one central laboratory with collection points across Mauritius, Madagascar, Seychelles & Reunion. This is set up with the Apollo Bramwell Hospital and pathology services will be available to patients in the hospital and across Mauritius.

Plans are to set up 25 collection points across these locations in the coming year, with a focus remaining on providing quality diagnostic facilities to this region. Metropolis will be opening 5 collection points with immediate effect at Port Louis, Curepipe, Moka, Quatre Bornes & Rose-Hill, with 2 more laboratories coming up across Central Flacq & Black River in the next 3 months. Investments planned around the joint venture are in the region of 50 million Mauritian Rupees.

Speaking at the occasion of the joint venture, Ameera Shah, managing director & chief executive officer, said it was looking to offer , 1000 tests being performed locally in Mauritius. We also have the advantage of offering 4500 tests with the best turnaround time. We would be the first and foremost in the Mauritius diagnostic industry to offer the widest test menu combined with the highest standard of quality at an affordable rate.”

According to Claudio Feistritzer-Rawat, Director of Metropolis Bramser Lab Services, Mauritius there is a growing need for quality diagnostics in the region . Our understanding of the market, combined with Metropolis’ expertise in global healthcare diagnostics, we look to bridge that gap while ensuring affordability and quality.”

Mauritius is ranked 9th out of 183 economies recently by the World Bank on the parameter of ‘Ease of Doing Business’. One of the world’s top tourist destinations, Mauritius is crowded throughout the year, ensuring that at present strength, the country is underpowered as far as diagnostic facilities go. Metropolis with a presence in UAE, Sri Lanka, South Africa, Kenya and Ghana is thus an ideal fit to ensure that affordable quality diagnostics are available for and in the island nation.